David D Hurd

Wake Forest University Health Sciences

$2,559,643

Attributed

$2,559,643

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $259.5K · FY2005–10

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

Funding mix

By agency

NIH$2,559,643 · 6

By mechanism

U10$2,192,941 · 1

R21$325,052 · 1

M01$41,650 · 4

Top collaborators

No co-investigators on record.

Most similar at Wake Forest University Health Sciences

Same institution · by research overlap

Edward G Shaw$22,365,759
Nancy E Avis$9,658,718
Isabelle M Berquin$1,923,047
Edward A Levine$1,866,520
Ralph B. Dagostino$15,515,654

Others in their field

Top investigators on “Clinical Trials”

Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
Bambra Strokes · Ppd Development Lp$526,656,217
Judith S. Currier · University Of California Los Angeles$504,273,077

Research focus

Clinical TrialsNeoplasm /Cancer DiagnosisClinical ResearchHuman SubjectTissue Resource /RegistryCancer Registry /ResourceNeoplasm /Cancer Radiation TherapyNeoplasm /Cancer GeneticsNeoplasm /Cancer VaccineNeoplasm /Cancer SurgeryAids Related Neoplasm /CancerNeoplasm /Cancer ChemotherapyFundingUniversitiesGrantForestHealth Care Cost /FinancingMalignant NeoplasmsNeoplasm /Cancer EpidemiologyResearch PersonnelNeoplasm /Cancer ImmunotherapyBone Marrow TransplantationCyclophosphamideDoxorubicin